These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38928403)

  • 1. Tailored Viral-like Particles as Drivers of Medical Breakthroughs.
    Travassos R; Martins SA; Fernandes A; Correia JDG; Melo R
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of virus-like particles of red-spotted grouper nervous necrosis virus in the aqueous state, and the vaccine potential of lyophilized particles.
    Lan NT; Kim HJ; Han HJ; Lee DC; Kang BK; Han SY; Moon H; Kim HJ
    Biologicals; 2018 Jan; 51():25-31. PubMed ID: 29174141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide presentation on primate erythroparvovirus 1 virus-like particles: In vitro assembly, stability and immunological properties.
    Del Carmen Morán-García A; Rivera-Toledo E; Echeverría O; Vázquez-Nin G; Gómez B; Bustos-Jaimes I
    Virus Res; 2016 Sep; 224():12-8. PubMed ID: 27523978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.
    Nooraei S; Bahrulolum H; Hoseini ZS; Katalani C; Hajizade A; Easton AJ; Ahmadian G
    J Nanobiotechnology; 2021 Feb; 19(1):59. PubMed ID: 33632278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
    Wang C; Beiss V; Steinmetz NF
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant-derived virus-like particles as vaccines.
    Chen Q; Lai H
    Hum Vaccin Immunother; 2013 Jan; 9(1):26-49. PubMed ID: 22995837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
    Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface Functionalization of Rod-Shaped Viral Particles for Biomedical Applications.
    Vaidya AJ; Solomon KV
    ACS Appl Bio Mater; 2022 May; 5(5):1980-1989. PubMed ID: 35148077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.
    Hyakumura M; Walsh R; Thaysen-Andersen M; Kingston NJ; La M; Lu L; Lovrecz G; Packer NH; Locarnini S; Netter HJ
    J Virol; 2015 Nov; 89(22):11312-22. PubMed ID: 26339047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of virus-like particles as vaccines and biological vehicles.
    Yan D; Wei YQ; Guo HC; Sun SQ
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10415-32. PubMed ID: 26454868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice.
    Huo Y; Wan X; Ling T; Wu J; Wang Z; Meng S; Shen S
    Mol Immunol; 2015 Dec; 68(2 Pt A):367-72. PubMed ID: 26375574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Rous sarcoma Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells.
    Kato T; Yui M; Deo VK; Park EY
    Pharm Res; 2015 Nov; 32(11):3699-707. PubMed ID: 26047779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
    Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope.
    Metz SW; Thomas A; White L; Stoops M; Corten M; Hannemann H; de Silva AM
    Virol J; 2018 Apr; 15(1):60. PubMed ID: 29609659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel coronavirus-like particles targeting cells lining the respiratory tract.
    Naskalska A; Dabrowska A; Nowak P; Szczepanski A; Jasik K; Milewska A; Ochman M; Zeglen S; Rajfur Z; Pyrc K
    PLoS One; 2018; 13(9):e0203489. PubMed ID: 30183777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qβ Coat Protein Trigger the Production of Neutralizing Antibodies.
    Guo Y; Guo R; Ma Y; Chang W; Ming S; Yang G; Guo Y
    Curr Top Med Chem; 2021 Oct; 21(14):1235-1250. PubMed ID: 34145995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human parvovirus B19 virus-like particles: In vitro assembly and stability.
    Sánchez-Rodríguez SP; Münch-Anguiano L; Echeverría O; Vázquez-Nin G; Mora-Pale M; Dordick JS; Bustos-Jaimes I
    Biochimie; 2012 Mar; 94(3):870-8. PubMed ID: 22192916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.